What were the primary drivers of the revenue increase?

Revenue increased due to higher revenue per equivalent admission, which rose by 7.6% in the third quarter and 8.2% for the nine months ended September 30, 2002, compared to the prior year. This was attributed to renegotiated managed care contracts, shifts from HMO to PPO business, and improved government reimbursement. Patient volumes, measured by equivalent admissions, also saw modest growth.

What caused the significant decrease in net income during the quarter?

The primary reason for the decrease in net income for the third quarter of 2002 was a $168 million impairment charge on investment securities. This was partially offset by the absence of a $112 million gain on facility sales that was recognized in the third quarter of 2001. Excluding these items, income before taxes would have shown an increase.

What is the company's exposure to ongoing governmental investigations and litigation?

HCA continues to be subject to extensive governmental investigations and litigation, including 'qui tam' actions, related to its business practices. While the company cooperates with these investigations, management acknowledges that an adverse outcome could result in substantial monetary fines, penalties, or exclusion from Medicare/Medicaid programs, potentially having a material adverse effect on its financial position, results of operations, and liquidity. The company has accrued $250 million related to an understanding with CMS for Medicare cost reports, but other outstanding civil issues remain unresolved.

How is HCA managing its debt and capital resources?

HCA has undertaken efforts to manage its debt, including issuing new debt and repaying amounts outstanding under its credit facility. The company's cash flow from operations has strengthened significantly, providing resources for capital expenditures and stock repurchases. HCA believes its cash flows, available credit, and access to debt markets are sufficient to meet its liquidity needs.

HCA 10-Q Quarterly Report Q3 FY2002 — Revenue, Net Income, EPS

Summary

HCA Healthcare, Inc. (HCA) reported a mixed financial performance for the quarter and nine months ending September 30, 2002. While revenues showed a notable increase year-over-year, net income and earnings per share declined significantly, primarily due to a substantial impairment charge on investment securities in the third quarter of 2002 and a gain on facility sales in the prior year's comparable period. The company continues to navigate ongoing governmental investigations and litigation, which pose material risks to its financial position and results of operations. Despite these challenges, HCA is focusing on strategic initiatives such as optimizing core assets, developing local health care networks, and improving operational efficiencies. The company also demonstrated strong cash flow from operations, supported by effective cost management and strategic debt reduction. Investors should monitor the resolution of legal and regulatory matters, as well as the company's ability to sustain revenue growth while controlling costs.

Key Highlights

1Revenues increased by 11.1% in the third quarter and 9.6% for the first nine months of 2002 compared to the prior year, driven by higher revenue per equivalent admission and increased patient volumes.
2Reported net income for the third quarter of 2002 decreased to $200 million from $256 million in the prior year, and for the nine-month period decreased to $935 million from $845 million, largely impacted by a $168 million impairment charge on investment securities in Q3 2002 and a $112 million gain on facility sales in Q3 2001.
3The company incurred a significant $168 million impairment charge on investment securities during the third quarter of 2002, primarily related to equity investments held by its insurance subsidiary.
4Cash provided by operating activities significantly increased to $1.96 billion for the nine months ended September 30, 2002, up from $821 million in the prior year, bolstered by a significant reduction in Federal government settlement payments compared to 2001.
5HCA announced plans for a substantial acquisition of the 14-hospital Health Midwest system for $1.125 billion, indicating a commitment to strategic growth.
6The company faces ongoing significant legal and regulatory scrutiny, including governmental investigations and various 'qui tam' actions, which management acknowledges could materially and adversely affect financial results.
7HCA repurchased approximately $282 million of its common stock in the third quarter of 2002 as part of its ongoing share repurchase program.

HCA Healthcare, Inc. Quarterly Report for Q3 Ended Sep 30, 2002

Summary

Key Highlights

Frequently Asked Questions